Patent · US Active

Imidazolyl progesterone antagonists

US9096641B2 · kind B2 · utility

0Cited by

13References

17Claims

0Family size

Assignee

Evestra, Inc. · US

Inventors

Klaus Nickisch · Berlin, DE
Walter Elger · Berlin, DE
Bindu Santhamma · San Antonio, US

Key dates

Filing date	Jun 5, 2013
Grant date	Aug 4, 2015
Priority date	—
Expiry date	Jun 22, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J71/001
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are imidazolyl compounds which either act as pure antiprogestins and methods of using such pure antagonists for gynecological indications and breast cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.